DESCRIPTION (Adapted from investigator's abstract): The long term goal of this
renewal is to better understand local and systemic immune responses to human
papillomavirus (HPV) infection in its natural setting of the cervix early in
its course as well as in states of persistence or clearance. The first aim of
the study is to examine the local immune response in the natural history of
cervical HPV infection in young women by comparing changes in the local
cervical cytokine milieu, specifically interferon (IFN)-gamma, interleukin
(IL)-12, IL-2, IL-10 and IL-4, in association: a) persistence, b) clearance of
initial and/or c) secondary infections, and d) development of SIL. The second
aim is to examine systemic response to HPV specifically cytotoxic T cell
response to HPV 16 infections in association with the four HPV states described
above. Four groups of women will be recruited for the study: 1) women with a
long history of persistent HPV infection, 2) women with secondary HPV type
infections, 3) adolescent and young women with evidence of initial HPV
infection, 4) women with a long history of persistent HPV negativity (control
group). Examinations for women from the first three groups seen every 4 months
will include samples for: HPV DNA, cytology, cervical cell cytokine analysis
using RT-PCR, C. trachomatis, N. gonorrhea, herpes simplex virus, bacterial
vaginosis, and peripheral blood CTL assays on women with HPV 16 infection. The
control group (HPV negative) will have similar examinations every 6 months and
have HPV serology to virus-like particles (VLP) to characterize HPV exposure
not defined by repeated HPV testing. The understanding of both local and
systemic immune responses to initial and subsequent HPV infections may be key
in vaccine or therapeutic developments.
Error Notice
The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.
We apologize for the inconvenience.
- The DCCPS Team.